For instance, CK2-mediated phosphorylation of PD-L1 at Thr285 and Thr290 prevents its binding to the CUL3 ubiquitin ligase adaptor, thereby inhibiting proteasomal degradation and maintaining high PD-L1 expression in tumor and dendritic cells [16]. Here, CD274 is linked to neoplasm.